Results 21 to 30 of about 211,078 (328)
Background Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of scientific evaluation of relevant promising biomarkers as well.
Bing-yao Pang +4 more
semanticscholar +1 more source
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
Background Few biomarkers can predict the efficiency of PD-1 blockade in patients with hepatocellular carcinoma (HCC). This study aimed to investigate the prognostic role of AFP and PIVKA-II in HCC patients receiving anti-PD-1 immunotherapy.
Xuqi Sun +8 more
semanticscholar +1 more source
Assessing mortgage default risk in full-recourse economies, with an application to the case of Chile
This paper is aimed at finding individual and systemic determinants of housing default in a full-recourse economy. We propose an empirical strategy that accounts for rare events and choice-based sampling bias and estimates the contribution of ...
Diego Avanzini +2 more
doaj +1 more source
Objective Hepatocellular carcinoma (HCC) has become a pressing health problem facing the world today due to its high morbidity, high mortality, and late discovery.
Jiaxin Zhang +9 more
semanticscholar +1 more source
Background Icaritin, an active ingredient of the Chinese herb Epimedium, plays an anti-tumor role in liver cancer by inhibiting the proliferation of hepatocellular cells and promoting their apoptosis.
Hui Li +7 more
semanticscholar +1 more source
Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection [PDF]
Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance.
Ahn, Sang Hoon +11 more
core +4 more sources
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is currently critical for improving the prognosis and reducing the associated economic burden.
Ting Wang, Kun-He Zhang
semanticscholar +1 more source
AFP-L3 for the diagnosis of early hepatocellular carcinoma
Background: The present study aimed to systematically evaluate the diagnostic value of an isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a meta-analysis.
Jian-Ming Zhou, Ting Wang, Kun-He Zhang
semanticscholar +1 more source
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
Hepatocellular carcinoma (HCC) is a major leading cause of cancer-related death worldwide. Alpha fetoprotein (AFP) is reactivated in a majority of hepatocellular carcinoma (HCC) and associated with poor patient outcomes.
Tianke Chen +15 more
semanticscholar +1 more source
Background At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC) surveillance is insufficient. It remains controversial whether prothrombin induced by vitamin K absence II (PIVKA-II) has a better diagnostic ...
Fei Xu +5 more
semanticscholar +1 more source

